Showing 17–32 of 40 results
Tirzepatide is a synthetic analog of gastric inhibitory polypeptide (GIP) that also exhibits glucagon-like peptide-1 (GLP-1) activity. This dual mechanism enables it to reduce blood glucose levels, enhance insulin sensitivity, and promote satiety. Originally developed for the treatment of type 2 diabetes, Tirzepatide has also demonstrated cardiovascular protective effects.
Tirzepatide is a synthetic analog of gastric inhibitory polypeptide (GIP) that also exhibits glucagon-like peptide-1 (GLP-1) activity. This dual mechanism enables it to reduce blood glucose levels, enhance insulin sensitivity, and promote satiety. Originally developed for the treatment of type 2 diabetes, Tirzepatide has also demonstrated cardiovascular protective effects.
Tirzepatide is a synthetic analog of gastric inhibitory polypeptide (GIP) that also exhibits glucagon-like peptide-1 (GLP-1) activity. This dual mechanism enables it to reduce blood glucose levels, enhance insulin sensitivity, and promote satiety. Originally developed for the treatment of type 2 diabetes, Tirzepatide has also demonstrated cardiovascular protective effects.
Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone involved in glucose metabolism. As a GLP-1 receptor agonist, Semaglutide mimics the effects of endogenous GLP-1, promoting insulin secretion and suppressing glucagon release in a glucose-dependent manner—a mechanism that helps lower blood sugar without causing hypoglycemia.
Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone involved in glucose metabolism. As a GLP-1 receptor agonist, Semaglutide mimics the effects of endogenous GLP-1, promoting insulin secretion and suppressing glucagon release in a glucose-dependent manner—a mechanism that helps lower blood sugar without causing hypoglycemia.
Humanin is a naturally occurring micro-peptide located in the mitochondria, where it plays a critical role in cellular protection. It is best known for its ability to prevent apoptosis (programmed cell death), helping to preserve cell viability under stress. As one of the few compounds that directly influence mitochondrial function, Humanin supports improved energy efficiency and cellular homeostasis. Ongoing research suggests it may have therapeutic potential in preventing or mitigating diseases of the heart, eyes, brain, and skeletal muscles.
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arginine 3) is a synthetic, modified analog of IGF-1. Due to its reduced affinity for IGF-binding proteins, IGF-1 LR3 remains active in circulation up to 120 times longer than native IGF-1. This significantly extended half-life leads to enhanced and prolonged biological activity. IGF-1 LR3 promotes cell division and growth, stimulates fat metabolism, and supports muscle repair and hypertrophy by inhibiting the muscle-growth limiting protein myostatin. Emerging research also suggests a potential role for IGF-1 LR3 in improving lactation in mothers with young offspring.
Ipamorelin is a short peptide sequence that binds selectively to the ghrelin/growth hormone secretagogue receptor. It is among the most selective growth hormone (GH) secretagogues identified, with laboratory studies demonstrating no impact on the release of ACTH, prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), or cortisol [1]. Due to its high specificity,…
Ipamorelin is a short peptide sequence that selectively binds to the ghrelin/growth hormone secretagogue receptor. It is recognized as one of the most selective growth hormone (GH) secretagogues, showing no effect on the release of ACTH, prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), or cortisol in laboratory studies [1]. Due to its high specificity, ipamorelin has garnered interest both as a therapeutic agent and as a model peptide for investigating the mechanisms behind selective GH receptor binding. It plays a crucial role in the growth and repair of musculoskeletal tissues.
Kisspeptin plays a crucial role in regulating hormone secretion related to reproduction. It has been shown to influence testosterone levels and modulate sex-related behaviors, including sexual drive and motivation. Emerging research also indicates that kisspeptin may help counteract certain effects of aging, potentially offering therapeutic benefits in age-associated reproductive decline.
KPV is an anti-inflammatory peptide that has demonstrated potential in various disease models. It has been most extensively studied in the context of inflammatory bowel disease, where it has shown encouraging results in reducing inflammation. Research also indicates that KPV and other alpha-MSH derivatives may support wound healing by helping to control inflammation, lower the risk of infection, and improve healing outcomes, including cosmetic appearance. These peptides are being investigated for their possible applications in wound care and scar management, particularly following surgical procedures.
LL-37 is a member of the cathelicidin family of peptides, recognized for its broad-spectrum antimicrobial properties. Research indicates that LL-37 exhibits antibacterial, antiviral, and antifungal activity, and may play a role in modulating inflammatory responses. Emerging studies also suggest potential effects on tumor-related pathways and promotion of angiogenesis (blood vessel formation) in certain experimental settings.
Melanotan-2 (MT-2) is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH), originally developed in the 1980s. Research indicates that MT-2 may enhance melanin production by stimulating melanocytes, leading to increased skin pigmentation. In addition to its effects on tanning, studies have suggested that Melanotan-2 may promote sexual arousal, suppress appetite, reduce compulsive or addictive behaviors, and potentially offer therapeutic benefits in early neurodevelopmental disorders, including autism.
MOTS-c is a mitochondrial-derived peptide (MDP) consisting of 16 amino acids that plays a vital role in regulating cellular metabolism. Produced within mitochondria, MOTS-c helps maintain energy balance by modulating pathways involved in glucose metabolism, insulin sensitivity, and cellular stress responses. It exerts its effects by moving to the nucleus, where it influences the expression of genes related to mitochondrial biogenesis and metabolic control, especially during metabolic stress.
Research indicates that MOTS-c can enhance exercise capacity, reduce obesity and insulin resistance, and positively impact various conditions including osteoporosis. Overall, MOTS-c promotes metabolic homeostasis, supports healthy aging, and shows promise in mitigating metabolic disorders and age-related diseases.
Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that is clinically used to evaluate and stimulate natural growth hormone production. As a truncated form of GHRH, Sermorelin preserves the essential region responsible for stimulating the pituitary gland. Beyond its clinical applications, it has gained research interest for its potential to enhance bone density, reduce scar formation, mitigate cognitive decline associated with dementia, and decrease seizure activity.
Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that is clinically used to evaluate and stimulate natural growth hormone production. As a truncated form of GHRH, Sermorelin preserves the essential region responsible for stimulating the pituitary gland. Beyond its clinical applications, it has gained research interest for its potential to enhance bone density, reduce scar formation, mitigate cognitive decline associated with dementia, and decrease seizure activity.
